JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

Search

Kala Pharmaceuticals Inc

Cerrado

0.52 -7.14

Resumen

Variación precio

24h

Actual

Mínimo

0.45

Máximo

0.56

Métricas clave

By Trading Economics

Dividendos

By Dow Jones

Próximas Ganancias

30 mar 2026

Kala Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 ene 2026, 22:31 UTC

Ganancias

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 ene 2026, 22:05 UTC

Ganancias

Stryker Logs Higher 4Q Profit On Sales Gains

29 ene 2026, 21:54 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 ene 2026, 21:36 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping

29 ene 2026, 23:57 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 ene 2026, 23:56 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 ene 2026, 23:53 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 ene 2026, 23:51 UTC

Ganancias

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 ene 2026, 23:49 UTC

Charlas de Mercado

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 ene 2026, 23:49 UTC

Charlas de Mercado

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 ene 2026, 23:47 UTC

Charlas de Mercado

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 ene 2026, 23:35 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 ene 2026, 23:32 UTC

Charlas de Mercado

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 ene 2026, 23:32 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

29 ene 2026, 23:15 UTC

Charlas de Mercado
Ganancias

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 ene 2026, 22:27 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 22:27 UTC

Ganancias

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 ene 2026, 22:12 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:55 UTC

Ganancias

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

29 ene 2026, 21:50 UTC

Ganancias

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Health Care Roundup: Market Talk

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

29 ene 2026, 21:49 UTC

Ganancias

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 ene 2026, 21:46 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 ene 2026, 21:36 UTC

Ganancias

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 21:30 UTC

Ganancias

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 ene 2026, 21:30 UTC

Ganancias

Apple 1Q Mac Rev $8.39B >AAPL

Comparación entre iguales

Cambio de precio

Kala Pharmaceuticals Inc previsión

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Finanzas

$

Acerca de Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat